BERNADETTE DUBE: Open Payments
NPI 1891114773 · NORTHPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 33 payments from 13 companies in 2025. Trend: 2023 $689 · 2024 $887 · 2025 $673
Food & beverage: $654Education: $19
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $105 |
| Novo Nordisk Inc | 5 | $104 |
| Merck Sharp & Dohme LLC | 5 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Amgen Inc. | 2 | $37 |
| Azurity Pharmaceuticals, Inc. | 2 | $33 |
| PFIZER INC. | 2 | $30 |
| Esperion Therapeutics, Inc. | 2 | $28 |
Products named: JARDIANCE, Wegovy, Kerendia, GEMTESA, VERQUVO, GARDASIL 9, REPATHA, EDARBI.
Industry payments across NY — which companies pay providers there.
